Stockscreener 앱 받기
421.85
1.32%
-5.65
시간 외 거래:
421.85
Thermo Fisher Scientific Inc 주식(TMO)의 최신 뉴스
U.S. Representative Darin LaHood Visits Rockford Thermo Fisher Scientific Site - WREX
$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today - Benzinga
Is Thermo Fisher Scientific Inc. (TMO) the Best American Dividend Stock to Buy According to Analysts? - Insider Monkey
Thermo Fisher Scientific Inc. (TMO): Among Value Stocks in Ken Fisher’s Portfolio - Insider Monkey
Controlling Genes Market Detailed in New Research Report By 2032 - openPR.com
Exosomes Market Projected To Witness Massive Growth, 2025-2032 - openPR.com
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center - Contract Pharma
Thermo Fisher Scientific Introduces the 5L DynaDrive Single-Use Bioreactor - ANTARA News
Macrophage Marker Market Detailed In New Research Report 2025 | - openPR.com
Is Thermo Fisher Scientific Inc. (TMO) the Best Large-Cap Value Stock to Buy as the Recession Hits? - Insider Monkey
Drug Abuse Testing Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Labs, Medtronic - GlobeNewswire
NMR Spectroscopy Market to Hit USD 2.08 Billion by 2032, Fueled by Pharmaceutical R&D and Rising Demand for Molecular Structure Analysis | SNS Insider - GlobeNewswire Inc.
Biochips Market Set to Witness Significant Growth by 2023 | - openPR.com
Thermo Fisher opens collaboration centre in US to help accelerate cell therapy development - BioSpectrum Asia
Assessing Thermo Fisher Scientific: Insights From 9 Financial Analysts - Benzinga
Thermo Fisher swaps HFCs for natural refrigerants in new large‑capacity and superspeed centrifuges - R&D World
Thermo Fisher Scientific Inc. (TMO): Among the Innovative Healthcare Stocks to Watch in 2025 - Insider Monkey
Theranostics Market Growth Analysis and Forecast 2025-2032 | - openPR.com
Leerink Adjusts Price Target on Thermo Fisher Scientific to $625 From $640, Maintains Outperform Rating - marketscreener.com
Stay Ahead of the Game With Thermo Fisher (TMO) Q1 Earnings: Wall Street's Insights on Key Metrics - Nasdaq
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development - Bakersfield.com
Lobbying Update: $1,450,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Nasdaq
Thermo Fisher Scientific named founding sponsor of LifeSciNKY - LINK nky
10 manufacturing acquisitions to know from Q1 - Manufacturing Dive
Bernstein Cuts Price Target on Thermo Fisher Scientific to $585 From $690, Keeps Outperform Rating - MarketScreener
Baird Cuts Price Target on Thermo Fisher Scientific to $603 From $660, Keeps Outperform Rating - MarketScreener
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Next Generation Sequencing Market on the Rise: Applications & - openPR.com
Thermo Fisher stock gains after Sartorius Q1 results (TMO) - Seeking Alpha
Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings - TradingView
Northern Kentucky-based LifeSciKY announces Thermo Fisher Scientific as founding sponsor - Northern Kentucky Tribune
Thermo Fisher Scientific - WACH
LifeSciKY inks partnership with Thermo Fisher Scientific as Founding Sponsor - Yahoo Finance
Thermo Fisher Scientific Introduces the 5L DynaDrive Single-Use Bioreactor to Simplify and Accelerate Process Development and Help Bring Therapies to Market Faster - MSN
Thermo Fisher acquires Solventum’s PF business in $4.1bn deal - Financier Worldwide
Thermo Fisher Scientific Stock Up 1.3% After Key Signal - Benzinga
Sickle Cell Anemia Testing and Screening Market Detailed In New - openPR.com
Thermo Fisher Scientific launches bench scale bioreactor enabling productivity, scalability and efficiency - BioSpectrum Asia
3d Cell Culture Market Set to Witness Significant Growth - openPR.com
Thermo Fisher Scientific Introduces the 5L DynaDrive Single-Use Bioreactor to Simplify and Accelerate... - lokmattimes.com
Thermo Fisher Scientific (NYSE:TMO) Launches 5L DynaDrive Bioreactor To Enhance Bioprocessing - simplywall.st
Thermo Fisher Scientific And Its Real Value (NYSE:TMO) - Seeking Alpha
BofA Securities Cuts Price Target on Thermo Fisher Scientific to $545 From $680, Keeps Buy Rating - MarketScreener
Helicobacter Pylori Diagnostics Market Is Booming Worldwide | Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc. - openPR.com
Thermo Fisher Scientific Introduces 5L DynaDrive Single-Use Bioreactor - Contract Pharma
SPONSORED Boys & Girls Clubs and Thermo Fisher Scientific fuel the future of STEM - Axios
Why Thermo Fisher Scientific (TMO) Is One of the Best Medical Stocks to Buy According to Billionaires - Insider Monkey
1.00%
자본화:
|
볼륨(24시간):